The Carl Zeiss Meditec Group’s long-term goal is to leave a lasting mark in the fields of ophthalmology and microsurgery. With our ambition to break new ground, our global teams have succeeded in developing innovative technologies, digital solutions and specific applications for the workflows of our customers, which enable them, for instance, to preserve vision into old age and fight brain tumors.
In addition to developing cutting-edge medical products, we focus on developing and establishing solutions that enable the secure and efficient management of health data, improve workflow automation, and enable the use of intelligent algorithms such as machine learning or artificial intelligence. Our specific workflow solutions for a wide variety of clinical workflows customer groups enable us, as a medical technology company, to take a holistic approach to addressing customer needs and to making a significant contribution to the digital transformation of the healthcare system.
For the ophthalmology market, the Ophthalmology strategic business unit (SBU) offers one of the most comprehensive product portfolios. It includes systems as well as consumables for cataract and corneal refractive surgery, offers products and solutions for the management of chronic eye diseases and for the diagnosis and treatment of posterior eye segment diseases. The Microsurgery SBU offers complete product solutions for visualization of minimally invasive surgical treatments for the fields of neurosurgery, ear, nose and throat, spine surgery, plastic and reconstructive surgery, and dentistry.